Florence Healthcare and Slope join forces to address site technology ecosystem demand
The companies say uniting will address research site demand for end-to-end solutions to increase efficiencies across all trials.
Slope is a global clinical trial execution platform for sites used by more than 75% of NCI-designated cancer centers for inventory and sample management. Florence Healthcare is a site enablement platform used by over 18,000 connected research sites in more than 55 countries.
The companies say the partnership stems from direct feedback from clinical researchers, recognizing their need for cohesive clinical technology across all trials, as opposed to the point solutions typically used trial by trial.
“The Slope-Florence partnership is a powerful combination. Florence’s vision to design a platform around sites’ needs to streamline operations, enable remote monitoring, and integrate study workflows is uniquely complementary to Slope,” says Rust Felix, CEO at Slope.
“Our combined solutions bring the industry one step closer to standardizing an end-to-end technology ecosystem built with and for sites.”
The Slope clinical trial execution platform provides an end-to-end workflow to ensure that research sites always have the right lab kits available while automatically guiding, documenting, and tracking all sample collection, processing, storing, and shipping activities.
The integration of Slope's platform with Florence's Electronic Investigator Site File (eISF), eBinders, allows sites to transfer critical documents, such as Site & Study Biospecimen Reports, Clinical Inventory Reports, and Study Lab Manuals, directly to Florence, improving workflow and efficiency.
Ryan Jones, CEO, at Florence Healthcare said: “Partnering with Slope significantly advances connectivity for research site processes and streamlining research operations and comes as a direct response to site need.
“Together, we will unlock the full potential of digital transformation at sites and help our clients address a broad range of challenges, reduce risk, and accelerate study timelines.”
This partnership, they say, grants the sponsors unrivaled access to data insights and documentation. Slope’s platform offers real-time biospecimen data, meaning sponsors can make informed study decisions, mitigate risks, and boost compliance.
Florence's SiteLink solution enables real-time access to study documents, improving accuracy, and compliance while accelerating study documentation cycles.
This collaboration is strategic and aligns with both companies' dedication to improving clinical trial execution at research sites, in a way that enables their daily operations. They say it is also a testament to their commitment to deliver solutions that meet the individual needs of research sites.
Florence Healthcare says its site enablement platform is designed to accelerate cures by better-connecting sponsors, CROs, and research sites. The company says it streamlines the clinical trial process, ‘enabling seamless collaboration and efficient management of clinical research workflows’.
Slope’s clinical trial execution platform orchestrates the entire biospecimen lifecycle, from kitting to testing at the lab, providing sponsors with accurate, real-time biospecimen data needed to inform timely study decisions.
